Published in Meta Gene on April 08, 2015
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Amino acid difference formula to help explain protein evolution. Science (1974) 15.19
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
The influenza virus resource at the National Center for Biotechnology Information. J Virol (2007) 11.33
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol (2002) 9.74
Predicting the evolution of human influenza A. Science (1999) 6.91
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A (1991) 4.78
The evolution of epidemic influenza. Nat Rev Genet (2007) 4.12
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
A predictive fitness model for influenza. Nature (2014) 2.73
Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A (2007) 2.67
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc Natl Acad Sci U S A (2005) 2.31
Update: influenza activity - United States, 2009-10 season. MMWR Morb Mortal Wkly Rep (2010) 2.27
Quantifying influenza vaccine efficacy and antigenic distance. Vaccine (2006) 1.97
Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis (2004) 1.95
ASAView: database and tool for solvent accessibility representation in proteins. BMC Bioinformatics (2004) 1.94
Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics (2008) 1.47
Natural selection on the influenza virus genome. Mol Biol Evol (2006) 1.47
Update: influenza activity--United States, 2003-04 season. MMWR Morb Mortal Wkly Rep (2004) 1.44
Structural basis of influenza virus neutralization. Ann N Y Acad Sci (2011) 1.37
Weathering the influenza vaccine crisis. N Engl J Med (2004) 1.35
Inferring stabilizing mutations from protein phylogenies: application to influenza hemagglutinin. PLoS Comput Biol (2009) 1.26
Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec (2014) 1.26
Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol (2012) 1.26
Origin and evolution of influenza virus hemagglutinin genes. Mol Biol Evol (2002) 1.19
Positive selection operates continuously on hemagglutinin during evolution of H3N2 human influenza A virus. Gene (2008) 1.17
Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine (2007) 1.16
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep (2011) 1.14
Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics (2009) 1.13
Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics (2013) 1.13
Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. Wkly Epidemiol Rec (2014) 1.05
Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J Virol (2012) 1.02
Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding. Biophys J (2012) 1.02
Low-dimensional clustering detects incipient dominant influenza strain clusters. Protein Eng Des Sel (2010) 0.98
A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2. Bioinformatics (2010) 0.93
Compensatory evolution of net-charge in influenza A virus hemagglutinin. PLoS One (2012) 0.91
Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev (2010) 0.90
Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One (2011) 0.90
Using a mutual information-based site transition network to map the genetic evolution of influenza A/H3N2 virus. Bioinformatics (2009) 0.90
Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol (2014) 0.88
Negative selection on neutralization epitopes of poliovirus surface proteins: implications for prediction of candidate epitopes for immunization. Gene (2004) 0.85
Predictability of antigenic evolution for H3N2 human influenza A virus. Genes Genet Syst (2013) 0.78
Timing of the emergence of new successful viral strains in seasonal influenza. J Theor Biol (2013) 0.78
Detection of positive selection eliminating effects of structural constraints in hemagglutinin of H3N2 human influenza A virus. Infect Genet Evol (2013) 0.76